Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Masquelier

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cancer Research|August 1, 1986
Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in miceM Masquelier, S Vitols, C Peterson
Journal of Medicinal Chemistry|November 1, 1980
Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestionM Masquelier, R Baurain, A Trouet
Journal of Medicinal Chemistry|April 1, 1985
Selective uptake of a toxic lipophilic anthracycline derivative by the low-density lipoprotein receptor pathway in cultured fibroblastsS G Vitols, M Masquelier, C O Peterson
The Journal of Rheumatology. Supplement|February 1, 1991
A French controlled multicenter study of intraarticular orgotein versus intraarticular corticosteroids in the treatment of knee osteoarthritis: a one-year followupB Mazières, A M Masquelier, M H Capron
Cellular and Molecular Life Sciences : CMLS|March 21, 2007
Glycoprotein IIb/IIIa blockade inhibits platelet aminophospholipid exposure by potentiating translocase and attenuating scramblase activityM Razmara, H Hu, M Masquelier, et al.
Journal of Lipid Research|October 1, 1996
Cryopreserve LDL in the presence of sucrose to protect the biologic propertiesM Rudling, S Vitols, M Masquelier, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1984
Cellular pharmacology of amino acid derivatives of daunorubicin and doxorubicin in suspension of renal proximal tubulesJ T Hjelle, R Baurain, M Masquelier, et al.
Targeted Diagnosis and Therapy|January 1, 1991
Lipoproteins, malignancy, and anticancer agentsC Peterson, M Masquelier, M Rudling, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1982
A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studiesA Trouet, M Masquelier, R Baurain, et al.
Journal of Medicinal Chemistry|November 1, 1980
Amino acid and dipeptide derivatives of daunorubicin. 2. Cellular pharmacology and antitumor activity on L1210 leukemic cells in vitro and in vivoR Baurain, M Masquelier, D Deprez-De Campeneere, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cancer Research|August 1, 1986
Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in miceM Masquelier, S Vitols, C Peterson
Journal of Medicinal Chemistry|November 1, 1980
Amino acid and dipeptide derivatives of daunorubicin. 1. Synthesis, physicochemical properties, and lysosomal digestionM Masquelier, R Baurain, A Trouet
Journal of Medicinal Chemistry|April 1, 1985
Selective uptake of a toxic lipophilic anthracycline derivative by the low-density lipoprotein receptor pathway in cultured fibroblastsS G Vitols, M Masquelier, C O Peterson
The Journal of Rheumatology. Supplement|February 1, 1991
A French controlled multicenter study of intraarticular orgotein versus intraarticular corticosteroids in the treatment of knee osteoarthritis: a one-year followupB Mazières, A M Masquelier, M H Capron
Cellular and Molecular Life Sciences : CMLS|March 21, 2007
Glycoprotein IIb/IIIa blockade inhibits platelet aminophospholipid exposure by potentiating translocase and attenuating scramblase activityM Razmara, H Hu, M Masquelier, et al.
Journal of Lipid Research|October 1, 1996
Cryopreserve LDL in the presence of sucrose to protect the biologic propertiesM Rudling, S Vitols, M Masquelier, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1984
Cellular pharmacology of amino acid derivatives of daunorubicin and doxorubicin in suspension of renal proximal tubulesJ T Hjelle, R Baurain, M Masquelier, et al.
Targeted Diagnosis and Therapy|January 1, 1991
Lipoproteins, malignancy, and anticancer agentsC Peterson, M Masquelier, M Rudling, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1982
A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studiesA Trouet, M Masquelier, R Baurain, et al.
Journal of Medicinal Chemistry|November 1, 1980
Amino acid and dipeptide derivatives of daunorubicin. 2. Cellular pharmacology and antitumor activity on L1210 leukemic cells in vitro and in vivoR Baurain, M Masquelier, D Deprez-De Campeneere, et al.
Pageof 3